Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy
Invest New Drugs
.
2021 Aug;39(4):1166.
doi: 10.1007/s10637-021-01097-3.
Authors
Francesco Pasqualetti
1
,
Alessandra Gonnelli
2
,
Paola Orlandi
3
,
Eleonora Palladino
2
,
Noemi Giannini
2
,
Giovanni Gadducci
2
,
Roberto Mattioni
2
,
Sabrina Montrone
2
,
Elisa Calistri
2
,
Chiara Maria Mazzanti
4
,
Sara Franceschi
4
,
Valerio Ortenzi
5
,
Cristian Scatena
5
,
Katia Zavaglia
6
,
Giuseppe Nicolo Fanelli
5
,
Riccardo Morganti
7
,
Orazio Santonocito
8
,
Guido Bocci
3
,
Antonio Giuseppe Naccarato
5
,
Fabiola Paiar
2
Affiliations
1
Radiation Oncology Unit, Pisa University Hospital, Via Roma 67, 56123, Pisa, Italy.
[email protected]
.
2
Radiation Oncology Unit, Pisa University Hospital, Via Roma 67, 56123, Pisa, Italy.
3
Department of Clinical and Experimental Medicine, University of Pisa, I-56126, Pisa, Italy.
4
Laboratory of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, Pisa, Italy.
5
Department of Translational Research and new technologies in Medicine and Surgery, University of Pisa, 56100, Pisa, Italy.
6
Division of Molecular Genetics, Department of Laboratory Medicine, Pisa University Hospital, Pisa, Italy.
7
Section of Statistics, Azienda Ospedaliero-Universitaria Pisana, Pisa University Hospital, Pisa, Italy.
8
Nurosurgery Unit, Area Vasta-NordOvest, Livorno General Hospital, Livorno, Italy.
PMID:
33704622
DOI:
10.1007/s10637-021-01097-3
No abstract available
Publication types
Published Erratum